Year Founded
2013
Ownership
Private
Employees
~100
Therapeutic Areas
Rare DiseasesDermatologyOphthalmology
Stage
Commercial
Modalities
Peptides

Evolved By Nature General Information

Commercialized Activated Silk 33B-alpha for skin barrier enhancement, with clinical evidence showing increased hydration and reduction in fine lines and irritation

Contact Information

Website
Primary Industry
[ "Life Sciences", "Biotech", "Chemicals & Materials" ]
Corporate Office
Needham, Massachusetts
USA

Drug Pipeline

Activated Silk 33B-alpha
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Evolved By Nature's pipeline data

Book a demo

Key Partnerships

Barentz, Anya Hindmarch, Alpine Creations, Apex Holdings, Richard Hoffmans GmbH & Co. KG, Cyclica Srl, Curtidos Bengala

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Evolved By Nature Funding

Deal TypeDateAmountStatusStage
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Evolved By Nature's complete valuation and funding history, request access »

Evolved By Nature Investors

The Kraft Group
Investor Type: Venture Capital
Holding: Minority
Roy Disney
Investor Type: Venture Capital
Holding: Minority
Jeff Vinik
Investor Type: Venture Capital
Holding: Minority
Investor Name
Investor Type
Holding
Investor Name
Investor Type
Holding
You're viewing 3 of 5 investors. Get the full list »